Skip to the main content

Original scientific paper

https://doi.org/10.17113/ftb.58.04.20.6424

Utjecaj diklofenaka na bakterijsku populaciju aktivnog mulja u reaktoru s pritokom supstrata

Barbara Kraigher ; University of Ljubljana, Biotechnical Faculty, Department of Food Science and Technology, Chair of Microbiology, Večna pot 111, 1000 Ljubljana, Slovenia
Ines Mandic-Mulec orcid id orcid.org/0000-0002-7629-3255 ; University of Ljubljana, Biotechnical Faculty, Department of Food Science and Technology, Chair of Microbiology, Večna pot 111, 1000 Ljubljana, Slovenia


Full text: english pdf 543 Kb

page 402-410

downloads: 190

cite

Full text: croatian pdf 543 Kb

page 402-410

downloads: 220

cite

Download JATS file


Abstract

Pozadina istraživanja. U zadnje vrijeme prisutnost i toksičnost farmaceutskih proizvoda u okolišu pobuđuju veliki interes javnosti. Diklofenak je nesteroidni protuupalni lijek koji se uvelike koristi, pa često dospijeva u otpadne vode, no usprkos tome postoji vrlo malo istraživanja o njegovom utjecaju na bakterije aktivnog mulja.
Eksperimentalni pristup. Ispitali smo utjecaj ovog lijeka na bakterijsku populaciju aktivnog mulja u reaktoru s pritokom supstrata kojem smo dodavali diklofenak tijekom 41 dana. Izmjerena je nitrifikacijska aktivnost bakterija aktivnog mulja, a promjena sastava bakterijske populacije praćena je molekularnom metodom za izravnu identifikaciju (T-RFLP) te uzgojem bakterija.
Rezultati i zaključci. Dodatak diklofenaka nije vidljivo utjecao na nitrifikacijsku aktivnost bakterija, a veća je promjena sastava bakterijske populacije opažena tek na kraju inkubacije (nakon 41 dana), kad je diklofenak bio dodan kao jedini izvor ugljika u otopinu koja simulira sastav otpadnih voda. Promjene sastava bakterijske populacije nakon obogaćivanja podloge diklofenakom primijećene su nakon izolacije i praćenja rasta bakterija na minimalnoj podlozi. Međutim, taksonomska pripadnost izolata nije odgovarala taksonima identificiranim metodom T-RFLP. Izolati dobiveni iz aktivnog mulja te korišteni kao inokulum spadali su u pet rodova bakterija: Comamonas, Arthrobacter, Acinetobacter, Citrobacter i Aeromonas, koje su poznate po sposobnosti razgradnje aromatskih spojeva. Međutim, nakon posljednjeg dodatka diklofenaka kao jedinog izvora ugljika minimalnoj podlozi izolirane su jedino bakterije vrste Pseudomonas.
Novina i znanstveni doprinos. Rezultati pokazuju da ispitani lijek, koji ima ograničenu biorazgradivost a često ga nalazimo u otpadnim vodama, ne utječe u velikoj mjeri na osjetljiv i bitan postupak nitrifikacije otpadnih voda. Osim toga, zaključeno je da izolirani sojevi bakterija koji su rasli na minimalnoj podlozi s diklofenakom kao jedinim izvorom ugljika mogu poslužiti kao model za proučavanje bakterijske razgradnje diklofenaka.

Keywords

aktivni mulj; farmaceutski proizvodi; diklofenak; T-RFLP identifikacija bakterija u populaciji; Pseudomonas

Hrčak ID:

250928

URI

https://hrcak.srce.hr/250928

Publication date:

15.1.2021.

Article data in other languages: english

Visits: 1.234 *




INTRODUCTION

Pharmaceuticals, generally regarded as being extremely advantageous for increasing human life expectancy, on the other hand represent a serious burden for the environment. Worldwide consumption rates of hundreds of tonnes of pharmaceuticals have a potential to cause undesirable ecological and human health effects (1-3). The pharmaceutical industry has increased enormously in recent years and currently represents one of the most profitable branches of industry. Consequently, substantial amounts of pharmaceuticals can reach and impact the environment, either through direct discharge of pharmaceuticals or due to inefficient elimination in wastewater treatment plants (WWTPs). Several studies have demonstrated that some pharmaceuticals are efficiently eliminated by WWTPs (ibuprofen, naproxen, ketoprofen), while others are resistant to biodegradation (diclofenac, clofibric acid) (4-7). Although many pharmaceuticals and their metabolites have been detected in aquatic environments and even in drinking water samples at concentrations ranging from ng/L up to hundreds of μg/L (4,8-10), there still remains a limited understanding of the extent and magnitude of their ecological effects.

Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) prescribed in daily doses of 75–150 mg to reduce inflammation. It acts as an analgesic to reduce pain in patients with arthritis or acute injury and can even be used to reduce menstrual pain (11). Over the counter use of diclofenac is approved in some countries for minor pains and fever associated with common infections and it has been estimated that 940 tonnes are consumed annually worldwide (11). Chemically, diclofenac is 2-[(2,6-dichlorophenyl)amino]-benzeneacetic acid. One benzene ring is chlorinated, which contributes to the recalcitrant nature of this pharmaceutical for biological degradation. The highly variable and relatively low biodegradation of diclofenac in WWTPs has been reported, mainly in the range of 21-40% (11). In the aquatic environment, diclofenac is one of the most frequently detected pharmaceuticals (12). It has been detected in drinking water (12) and has caused the death of millions of vultures in Southeast Asia through its use in veterinary medicine (13,14). In the liver, kidneys and gills of rainbow trout, cytopathology occurred already at concentrations of 1 μg/L (15). Studies of diclofenac influence on microbial communities are scarce. Microorganisms in lotic biofilms were inhibited at diclofenac concentrations of 100 μg/L (16). At very high concentrations (50-100 mg/L), it was shown to inhibit bacterial growth in most of the tested Gram-positive and Gram-negative strains by inhibiting DNA synthesis (17).

In our previous studies (18,19), we have shown that a mixture of selected commonly used pharmaceuticals including diclofenac caused shifts in the community structure of activated sludge in pilot bioreactors. The aim of this study is to evaluate the effect of diclofenac, the most recalcitrant drug in the pharmaceutical mixture (5), on the nitrification activity and the community structure of activated sludge in fed-batch reactors exposed to increasing concentration of diclofenac. Additionally, we used the enrichment culture approach to isolate bacteria that are capable of growing on minimal agar plates with diclofenac added as the only carbon source.

MATERIALS AND METHODS

Experimental setup and sampling

Batch cultures of activated sludge were prepared in 500-mL Erlenmeyer flasks containing 200 mL of artificial wastewater, which was prepared by dissolving a mineral nutrient composition in tap water, simulating the composition of real municipal wastewater (5). The following chemicals were used: yeast extract (130 mg/L), casein peptone (130 mg/L), meat extract (130 mg/L; all Biolife Italiana, Milano, Italy), CH3COONH4 (317 mg/L), NH4Cl (40 mg/L; both Kemika, Zagreb, Croatia), K2HPO4 (24 mg/L), KH2PO4 (8 mg/L), CaCO3 (100 mg/L), MgCO3 (100 mg/L), NaCl (40 mg/L; all Sigma-Aldrich, Merck, Gillingham, UK), and FeSO4·7H2O (5 mg/L; Merck, Darmstadt, Germany). Each flask (fed-batch reactor) was inoculated with 20 mL of activated sludge obtained from the R200 reactor described by Kraigher et al. (18), which was operated for 18 months with artificial wastewater containing 200 μg/L of each of the following pharmaceuticals: diclofenac, ibuprofen, naproxen, ketoprofen and clofibric acid. This sludge was selected because it contained a biomass already adapted to the selected concentration of pharmaceuticals and it was expected that potential changes in community structure and enrichment of bacteria capable of degrading diclofenac would be detected sooner. Fed-batch reactors were incubated at 220 rpm and 28 °C in the darkness. Activated sludge was exposed to either 200 μg/L diclofenac (Sigma-Aldrich, Merck) throughout the entire experiment, or to 5 mg/L diclofenac (with increasing concentrations from 1 to 5 mg/L in the first 10 days of incubation). One fed-batch reactor was incubated without the addition of pharmaceuticals. The fed-batch reactors were operated in the following way throughout the experiment: the hydraulic retention time of two days was maintained by settling down the sludge every two days (three days over the weekends), decanting the medium, and adding fresh artificial wastewater with (or without) diclofenac. Each time the samples of influents (artificial wastewater) and effluents (decanted medium) were taken and kept frozen until N-NH4+ and N-(NO2-+NO3-) concentrations were analysed by continuous flow analyser (FlowSys Alliance Instruments, Salzburg, Austria). After 20 days of incubation, the artificial wastewater without organic carbon (i.e. without casein peptone, CH3COONH4, meat and yeast extract) was used to feed the fed-batch reactors which were incubated for additional three weeks. Activated sludge for bacterial community analyses was sampled (1 mL) at indicated time intervals and stored at –80 °C until DNA extraction.

Bacterial community analyses

Terminal restriction fragment length polymorphism (T-RFLP) analysis was used to compare bacterial community structures. DNA was extracted from 1-mL subsamples (two independent DNA isolations were obtained for each sample) using the UltraClean soil DNA isolation kit (MoBio Solano Beach, CA, USA) according to the manufacturer’s instructions. Isolated total community DNA (concentration of 50-100 ng/μL) was checked on a 1% agarose gel and compared to the Gene Ruler DNA Ladder Mix (Thermo Fisher Scientific Baltics, UAB, Vilnius, Lithuania) to estimate the size and concentration. Purified DNA was then used as a template for polymerase chain reaction (PCR) with 16S rRNA gene primers 27f labelled with 6-FAM (6-carboxyfluorescein) at the 5’ end and 927r (20) for the total community analyses, following the protocols described by Kraigher et al. (18). Restriction with restriction enzyme MspI (Thermo Fisher Scientific Baltics, UAB), ethanol precipitation and T-RFLP profiling were performed. Profiles were generated using ABI PRISM 310 DNA sequencer and GeneScan analysis software (21). Terminal restriction fragments (T-RFs) with peak heights of less than 50 fluorescence units and T-RFs that were less than 50 bp long were excluded from the analyses. T-RFLP profiles of duplicate DNA isolations per sample were analysed using the BioNumerics program v. 6.6 (22). Normalized intensity values and the positions of the detected bands were used for cluster analysis, while peaks representing less than 1% of the total fluorescence of all peaks in a sample were excluded from the analysis. Pearson’s correlation coefficient, which considers both fragment length and peak height, was used to calculate similarity coefficients. A dendrogram was then constructed using the unweighted pair-group method with arithmetic means (UPGMA) algorithm.

Isolation of bacteria capable of growing on minimal plates with diclofenac

Bacteria were isolated from the activated sludge that was used as inoculum for the incubation experiment and from the fed-batch cultures at the end of the experiment (after 41 days of incubation with diclofenac, with the last 20 days without the addition of any other external carbon source except for diclofenac). Mineral medium (MM) agar plates supplied with 20 mg/L of diclofenac as the only carbon and energy sources were used for isolation. MM agar plates consisted of (in g/L): 3.5 Na2HPO4·2H2O (Sigma-Aldrich, Merck), 1 KH2PO4 (Sigma-Aldrich, Merck), 0.5 (NH4)2SO4·2H2O (Merck), 0.1 MgCl2·6H2O (Honeywell-Fluka, Basel, Switzerland), 0.05 Ca(NO3)2·4H2O (Honeywell-Fluka), 15 highly purified agar (Biolife Italiana) at pH=7.25 and finally 1 mL trace element solution SL-4 was added. The trace element solution SL-4 consisted of (in g/L): 0.5 EDTA (Sigma-Aldrich, Merck), 0.2 FeSO4·7H2O (Merck), 0.01 ZnSO4·7H2O (Merck), 0.003 MnCl2·4H2O (Merck), 0.03 H3BO3 (Merck), 0.02 g CoCl2·6H2O (Honeywell-Fluka), 0.001 g CuCl2·2H2O (Sigma-Aldrich, Merck), 0.002 NiCl2·6H2O (Sigma-Aldrich, Merck) and 0.003 Na2MoO4·2H2O (Kemika). The activated sludge was centrifuged, washed with MM medium and then different dilutions were plated on MM plates with diclofenac and incubated in darkness at 28 °C. Distinct colonies were reinoculated on R2A plates (R-2A agar; Fluka Analytical, Sigma-Aldrich Chemie GmbH, Merck) several times until pure cultures were obtained, and then verified for growth on MM plates with diclofenac as a sole carbon source. Finally, purified colonies were grown overnight in yeast extract broth consisting of (in g/L): 3 yeast extract and 6 peptocomplex (Biolife Italiana), then frozen in glycerol (15%) and stored at –80 °C.

Identification of the isolated bacteria

The isolated bacteria were grown in yeast extract broth (Biolife Italiana), overnight at 28 °C and 220 rpm in darkness. The overnight cultures were then boiled for 10 min and 3 μL of boiled cells were used as a template to amplify the 16S rRNA genes using primers 27f and 1406R (23) and PCR conditions as described above for T-RFLP. PCR reactions were purified with QuickClean 5M PCR purification kit (GenScript USA Inc., Piscataway, NJ, USA) and sequenced by Macrogen Inc. (Seoul, Korea). Sequences of 700-800 bp were obtained. Some isolates were selected for sequencing with both forward and reverse primers (which gave approx. 300 bp of overlapping sequence) to get more reliable information about the identity of the isolates. The partial 16S rRNA gene sequences were identified by Basic Local Alignment Search Tool (BLAST; (24)) searches at NCBI and deposited in the GenBank database under accession numbers JF928537 to JF928555. GenBank sequences, which were identified by BLAST searches to be most similar to the isolate sequences, were downloaded and included in the phylogenetic tree reconstruction using neighbour-joining method with 500 bootstrap replicates and the Maximum Composite Likelihood evolutionary model within the MEGA v. 4 (25).

RESULTS AND DISCUSSION

Nitrification activity during the experiment

Studies of xenobiotics in activated sludge generally focus on their degradation efficiency. However, it is also very important to investigate the influence of xenobiotics on microbial activities responsible for the key functions of WWTPs, such as nitrogen removal. In the previous study (19), a higher concentration of nitrate was detected in the reactors containing 50 μg/L of the pharmaceutical mix than in the reactors with lower concentration of pharmaceutical mix (5 or 0 μg/L), while no significant influence of pharmaceuticals on ammonium removal was observed. In this study, nitrification activity of the activated sludge in the fed-batch reactors exposed to diclofenac was monitored every two to three days after settling down the sludge by measuring ammonium, nitrite and nitrate concentrations in the medium (Fig. 1). Nitrification performance as reflected by ammonium removal was high in all batch reactors (nearly 100%), irrespective of the diclofenac concentration (Fig. 1a). A short adaptation period was observed during the first 4-6 days when the seeding sludge was transferred from the pilot reactor to the fed-batch reactors without diclofenac or its lower concentration (200 μg/L). This lag period was not observed in the fed-batch reactors with a high concentration of diclofenac (1 mg/L at the beginning). However, irrespective of diclofenac concentration, almost no ammonium (mostly less than 0.5 mg/L) remained in the fed-batch reactors after six days of incubation. A longer adaptation period for nitrite oxidation was observed as its accumulation was detected for 13-15 days (Fig. 1b). After this period, nitrite almost totally disappeared, while nitrate concentrations increased. After the first 20 days, when all carbon sources except diclofenac were excluded and the influent ammonium concentration was lower (it dropped from approx. 65 to approx. 9.5 mg/L when all carbon sources were eliminated), the concentration of nitrate fell rapidly and was relatively constant in all fed-batch reactors until the end of the experiment (Fig. 1c). In the previous study (19), the concentration of nitrate in the effluent of the reactors was very low (except in the reactors with 50 μg/L of pharmaceuticals). This was attributed to the denitrification in the reactors under the microaerophilic conditions that were probably present in the activated sludge flocs. In contrast, in this experiment the reactors were thoroughly shaken and flocs could not develop. However, despite different conditions in the pilot reactors and fed-batch reactors used in this experiment, ammonium removal was high in both systems and inhibition of nitrification process by diclofenac was not detected.

Fig. 1 The concentrations of: a) ammonium, b) nitrite and c) nitrate in the small fed-batch reactors during the experiment. Vertical dashed lines indicate the time point where all carbon sources except diclofenac were excluded from the influent artificial wastewater. Dc=flask with increasing diclofenac concentration up to 5 mg/L, Dc200=flask with γ(diclofenac)= 200 μg/L, 0=flask without diclofenac, influent=artificial wastewater used to feed the reactors
FTB-58-402-f1

Bacterial community shifts during the experiment

The bacterial community structure of activated sludge in the fed-batch reactors was evaluated by T-RFLP at the beginning of the experiment, after 20 days of incubation with diclofenac (0.2 or 5 mg/L) and at the end of the experiment (41 days), when the sludge was incubated for the last 21 days with diclofenac as the only carbon source. Comparison of T-RFLP profiles of bacterial communities is shown as a dendrogram inFig. 2. Community profiles representing inoculum and the first four days of experiment (samples designated t0, 2d, 4d), clustered separately from the samples after 20 days (samples designated 20d) and after 41 days (41d) of incubation, indicating shifts in bacterial communities over time. This could partly be attributed to the adaptation to the altered conditions when transferring the sludge from the pilot reactors to the fed-batch reactors (communities diverged to approx. 65% similarity). The highest divergence (only approx. 40% similarity) was observed when all carbon sources were excluded from the artificial wastewater and diclofenac served as the only carbon source (Fig. 2). Also, the community profile of the sludge incubated without diclofenac diverged most from the other two communities at the end of the experiment. The similarity among the replicate samples was at least 80%, while similarity between fed-batch reactors with or without diclofenac at the end of the experiment was approx. 55% (Fig. 2).

Fig. 2 Comparison of the activated sludge bacterial community profiles treated with different concentrations of diclofenac at three different times of incubation. The dendrogram of the terminal restriction fragment length polymorphism (T-RFLP) profiles was generated based on Pearson’s correlation using the unweighted pair-group method with arithmetic means (UPGMA) method. 0=reactor without diclofenac, Dc200=reactor with γ(diclofenac)=200 μg/L, Dc=reactor with increasing diclofenac concentration up to 5 mg/L, t0=activated sludge used for seeding the flasks, A and B=DNA isolations from duplicate samples, 2d, 4d, 20d, 41d=samples taken after 2, 4, 20 and 41 days of the incubation
FTB-58-402-f2

Fig. 3 shows the T-RFLP profiles of some representative samples. Major differences could be observed in the profiles at the end of incubation, where at least two new peaks are evident. One of the two T-RF peaks was present in all samples at the end of the experiment (on the right end of the profiles, the length was not estimated since it was already above the range of our standard, which was 500 bp) and could be attributed to the absence of carbon sources during the last 21 days of incubation. We affiliated the most distinctive peak, which clearly appeared only in the fed-batch reactors with diclofenac and not in the control (Fig. 3), with T-RF of 292 bp. This peak was identified by in silico T-RFLP analyses of the clone library constructed previously (18), considering the T-RF drifts of in silico predicted and the experimental T-RF lengths of approx. 4 bp (19). Based on our previous analyses (19) the 292 bp T-RF could be affiliated with Acidobacteria phylum. Representatives of this phylum are very difficult to isolate (only a few representatives have been isolated so far) and are therefore not well characterized metabolically, although molecular analyses indicate their widespread presence across variety of environments (26,27).

Fig. 3 Terminal restriction fragment length polymorphism (T-RFLP) profiles of the bacterial communities in the flasks at different times of incubation. The most distinctive change in the T-RF of 292 bp (indicated by an arrow) occurred in the flasks treated with diclofenac without any other carbon source. The other T-RF indicated occurred in all flasks at the end of the experiment. t0=activated sludge used for seeding the flasks, 0=reactor without diclofenac, Dc200=reactor with γ(diclofenac)=200 μg/L, Dc=reactor with increasing diclofenac concentration up to 5 mg/L, 2d, 20d, 41d=samples taken after 2, 20 and 41 days of incubation experiment
FTB-58-402-f3

Our results indicated that there was no significant influence of dicofenac on the bacterial community structure in activated sludge during the first 20 days of the experiment, when additional carbon was still present, even if its concentration was 5 mg/L. This is not surprising as the community has been previously adapted to a variety of pharmaceuticals. Moreover, consistently with Zhang et al. (11), who reported relatively low degradation efficiency for diclofenac in WWTPs, bacteria will preferentially degrade more easily degradable carbon source. However, a detectable change in bacterial community structure occurred when diclofenac was provided as the only carbon source and other carbon sources were removed. This change indicates that one or more microbial types became enriched in the setting and that adapted sludge has a potential for growth on diclofenac and consequently its removal. However, we cannot exclude the possibility that this shift might be the result of enrichment of certain diclofenac-tolerant community members that grow on dead biomass. Therefore, further studies are needed to characterize the species responsible for the changed pattern.

Isolation of bacteria capable of growth on minimal agar plates with diclofenac as a sole carbon source

As we observed a change in microbial community structure due to diclofenac, we aimed to isolate the bacteria capable of growing on minimal medium containing diclofenac as the only carbon source. Bacteria were isolated from the original bioreactor sludge used for inoculating the fed-batch reactors and from the sludge exposed to higher concentrations of diclofenac after the 41-day experiment. From the first sample, representatives of five genera were isolated, while after incubation in the absence of other sources of carbon during the last 21 days of experiment, only two different Pseudomonas sp. were isolated. InFig. 4, a phylogenetic tree indicates the affiliation of the isolates obtained in this study with the related strains found by BLAST searches of the 16S rRNA genes. Eleven isolates from the seeding sludge designated Dc1-Dc11 belonged to Gammaproteobacteria, Betaproteobacteria and Actinobacteria. From the activated sludge in fed-batch reactors, after enrichment experiment we isolated eight strains (Dc21-Dc28) which were taxonomically less diverse and belonged to Pseudomonas sp. (Gammaproteobacteria). Changes in the community structure before and after the enrichment with diclofenac as the only carbon source were detected by culture-independent molecular methods as well as with the selective isolation of bacteria capable of growing on diclofenac. Affiliations and identities of partial 16S rRNA genes of the isolates with the related strains are shown inTable 1. Five species isolated from the seeding sludge showed 99-100% sequence identity to related strains in the GenBank, which harbour representatives previously indicated for their potential to degrade aromatic compounds. Majority (7) of the obtained isolates were relatives of Comamonas testosteroni, which is able to mineralize complex and xenobiotic aromatic compounds as the sole carbon and energy source (28,29). Boon et al. (30) demonstrated that wastewater reactors augmented by C. testosteroni I2 gfp showed accelerated degradation of toxic chlorinated aromatic compound 3-chloroaniline. This strain also protected the nitrifying bacterial community, allowing for its faster recovery from the toxic shocks. Acinetobacter sp. and Arthrobacter sp. HY2 degraded p-nitrophenol (31,32), while Citrobacter strains isolated from various effluent treatment plants degraded a range of aromatic compounds and biotransformed mono- and dichlorophenols (33). Species from the genus Aeromonas are commonly reported in clinical studies, but they also degrade aromatic compounds (34).

Fig. 4 Phylogenetic tree based on partial 16S rRNA gene sequences showing the affiliations of the isolates obtained in this study (printed bold) to similar known species found by Basic Local Alignment Search Tool (BLAST) searches in the GenBank database (22). The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (500 replicates) is shown at the nodes
FTB-58-402-f4
Table 1 Identification and similarity of the isolates with the known species as found by Basic Local Alignment Search Tool (BLAST) searches in the GenBank (22)
Strains with sequences similar to the isolates (BLAST search)Similarity /%Strain information found in the GenBank
Seeding activated sludgeComamonas testosteroni strain I2gfp (EF421407)
Comamonas sp. PD3 (EF373535)
1299/1299 (100)
1297/1299 (99.9)
3-chloroaniline-degrading Comamonas testosteroni strain, I2gfp, isolated from wastewater
phenol-degrading bacteria
Aeromonas media strain 480a (FJ168773)1309/1311 (99.9)analysis of 16S rRNA gene mutations in a subset of Aeromonas strains
Arthrobacter sp. R4 (FN392695)
Arthrobacter sp. TD3 (EF468655)
A. protophormiae SSCT48 (AB210984)
1272/1272 (100)
1276/1286 (99.2)
1274/1285 (99.1)
microcystin-degrading bacteria isolated from water
2,4,6-trinitrotoluene-degrading bacteria
bacteria isolated from sewage sludge compost
Citrobacter gillenii (AF025367)1304/1305 (99.9)Citrobacter phylogeny by 16S rRNA gene sequence comparison
Acinetobacter sp. E-9 (FJ392124)
Acinetobacter sp. bk_2 (HQ538658)
1261/1263 (99.8)
1299/1301 (99.9)
phenol-degrading bacteria isolated from leaf microbial communities
representative strains isolated from bulking activated sludge
Sludge after enrichmentP. putida strain PNP-1 (EU874452)
P. putida strain PL2 (FJ204928)
P. putida F1 (NC009512)
P. putida KT2440 (NC002947)
P. aeruginosa LESB58 (NC011770)
1299/1299 (100)
1298/1299 (99.9)
1299/1299 (100)
1298/1299 (99.9)
1256/1308 (96.0)
p-nitrophenol-degrading bacteria isolated from soil
strain capable of biodegrading polycyclic aromatic hydrocarbons isolated from polluted soil
completely sequenced Pseudomonas putida F1, isolated from a polluted creek in Urbana, IL, USA
complete genome sequence of Pseudomonas putida KT2440
the Liverpool epidemic strain of Pseudomonas aeruginosa

Although the same method of isolation was used for all isolates in this work, the isolates from the seeding sludge were more diverse than those exposed to diclofenac without other carbon sources. The seeding sludge from the reactor was exposed for 18 months to diclofenac (in a mixture of five different pharmaceuticals at concentration of 200 µg/L) with many other carbon sources always present in artificial wastewater, which enabled the growth of co-metabolizing bacteria, while in the fed-batch reactors, enrichment of bacteria able to utilize diclofenac as the sole carbon source was favoured. Seven out of eight Pseudomonas isolates were affiliated with Pseudomonas putida (Fig. 4), which is a metabolically versatile bacterium closely related to P. aeruginosa and important for bioremediation of sites contaminated with multiple aromatic hydrocarbons. The partial 16S rRNA gene sequence of our isolate was 100% similar to that of P. putida F1, which is one of the most well-studied aromatic hydrocarbon-degrading bacterial strains (35).

Importance of the isolated bacteria

Many bacteria, which are able to degrade different pollutants, are being isolated from various polluted environments. Our results suggest that the same species or genera previously characterized to be metabolically versatile and able to degrade diverse aromatic compounds, emerging in the environment, might also be able to degrade diclofenac. In comparison with ibuprofen, the diclofenac phenol ring is halogenated, which contributes to the recalcitrance of this drug. However, when we performed similar enrichment experiments with ibuprofen instead of diclofenac, almost identical bacteria were isolated (as reflected from partial 16S rRNA gene sequence; data not shown). In addition, shifts in microbial community structure were very similar to the diclofenac-enriched community, as the same distinctive T-RF occurred in the presence of both pharmaceuticals when other carbon sources were absent (data not shown).

We performed T-RFLP analyses of the isolated strains to identify specific T-RFs in the total community profiles. These only represented very minor T-RFs (with low relative peak heights), suggesting that the isolated bacteria are not the most abundant in polluted environments. None of the isolates corresponded to the distinctive T-RF of 292 bp, enriched at the end of incubation with diclofenac as the only carbon source. It seems that bacteria in the activated sludge representing this T-RF cannot be isolated by the method applied here and alternative approaches will need to be devised in the future. Nevertheless, we isolated seven strains capable of growing on minimal medium with diclofenac as a sole carbon source and these represent potential models that can be applied to better understand the metabolism of diclofenac and study their potential for its removal from wastewater in monoculture and in more complex communities, such as activated sludge.

Since pharmaceuticals are usually present in wastewaters at concentrations of μg/L or less, it is possible that they do not serve as the sole carbon sources for the wastewater microorganisms and degradation in the presence of high concentrations of many different carbon sources is probably more relevant for the degradation of diclofenac in WWTPs. Gröning et al. (36) have proposed that the apparent lack of degradative potential of diclofenac as well as the failure to detect an enrichment of diclofenac-depleting microbial activity both indicate a co-metabolic nature of diclofenac transformation. Similarly, Pieper (37) suggested that polychlorinated biphenyl (PCB)-degrading organisms do not usually use PCBs as an energy source, but rather catabolize these substrates co-metabolically. In fact, there are a few reports in the recent years about the degradation of diclofenac: some indicate white-rot fungi as biodegraders (38), while the first bacterium capable of using diclofenac as its sole carbon source has been reported only recently (39). They showed that the isolated strain Brevibacterium sp. D4 could biodegrade 35% of diclofenac as a sole carbon source, while periodic feeding with acetate as a supplementary carbon source enhanced biodegradation to the levels up to 90%. Similarly, it was demonstrated that the isolated strain Enterobacter hormaechei D15 could biodegrade diclofenac at an elimination rate of 52.8%, while in the presence of glucose as a supplementary carbon source, degradation rate increased to approx. 82% (40). Our preliminary assays of diclofenac degradation by the isolated bacteria have similarly indicated better elimination rates when tests were performed in the presence of other carbon sources in addition to diclofenac. This might be a consequence of the co-metabolic nature of diclofenac degradation or merely the lower growth rate of the isolates when only diclofenac is available as a carbon source. Evidently, co-metabolism of diclofenac is more efficient than its degradation as a sole carbon source and search for bacteria in a consortium able to degrade it co-metabolically should be adapted accordingly.

CONCLUSIONS

Our results indicate that nitrification process in small fed-batch reactors was efficient and was not detectably affected by relatively high concentrations of diclofenac (up to 5 mg/L), suggesting that the selected recalcitrant and commonly detected pharmaceutical does not influence the sensitive and important process of wastewater treatment. Moreover, bacterial communities adapted to 0.2 mg/L diclofenac did not strongly change at higher diclofenac concentrations (5 mg/L), at least under the conditions applied in our experiment, which could explain the low diclofenac degradation efficiency often observed in wastewater treatment plants. Influence of diclofenac at concentrations of 0.2 and 5 mg/L on the structure of activated sludge microbial communities was only evident when other carbon sources were not added. The isolated strains obtained in this study are very important as potential model bacteria to study bacterial diclofenac degradation. However, the disagreement between the bacterial community structure determined by the cultivation-independent approach and the bacterial isolation needs to be taken into account.

ACKNOWLEDGEMENTS

The authors are grateful to Petra Zeme and Simona Leskovec for their technical assistance.

Notes

[1] Financial disclosure FUNDING

The authors acknowledge the financial support from the state budget by the Slovenian Research Agency (project Z1-0776: Influence of pharmaceutical residues on activated sludge microbial communities in a pilot wastewater treatment plant, and program P4-0116: Microbiology and biotechnology of food and environment).

[2] Conflicts of interest CONFLICT OF INTEREST

The authors declare no conflicts of interest.

REFERENCES

1 

Daughton CG, Ternes TA. Pharmaceuticals and personal care products in the environment: Agents of subtle change? Environ Health Perspect. 1999;107 Suppl 6:907–38. https://doi.org/10.1289/ehp.99107s6907 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/10592150

2 

Kasprzyk-Hordern B, Dinsdale RM, Guwy AJ. The occurrence of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs in surface water in South Wales, UK. Water Res. 2008;42(13):3498–518. https://doi.org/10.1016/j.watres.2008.04.026 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/18514758

3 

Ziylan A, Ince NH. The occurrence and fate of anti-inflammatory and analgesic pharmaceuticals in sewage and fresh water: Treatability by conventional and non-conventional processes. J Hazard Mater. 2011;187(1-3):24–36. https://doi.org/10.1016/j.jhazmat.2011.01.057 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/21315511

4 

Ashton D, Hilton M, Thomas KV. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci Total Environ. 2004;333(1-3):167–84. https://doi.org/10.1016/j.scitotenv.2004.04.062 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/15364527

5 

Kosjek T, Heath E, Kompare B. Removal of pharmaceutical residues in a pilot wastewater treatment plant. Anal Bioanal Chem. 2007;387(4):1379–87. https://doi.org/10.1007/s00216-006-0969-1 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/17203254

6 

Langenhoff A, Inderfurth N, Veuskens T, Schraa G, Blokland M, Kujawa-Roeleveld K, et al. Microbial removal of the pharmaceutical compounds ibuprofen and diclofenac from wastewater. BioMed Res Int. 2013;2013:325806. https://doi.org/10.1155/2013/325806 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/24350260

7 

Quintana JB, Weiss S, Reemtsma T. Pathways and metabolites of microbial degradation of selected acidic pharmaceutical and their occurrence in municipal wastewater treated by a membrane bioreactor. Water Res. 2005;39(12):2654–64. https://doi.org/10.1016/j.watres.2005.04.068 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/15979124

8 

Carballa M, Omil F, Lema JM. Comparison of predicted and measured concentrations of selected pharmaceuticals, fragrances and hormones in Spanish sewage. Chemosphere. 2008;72(8):1118–23. https://doi.org/10.1016/j.chemosphere.2008.04.034 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/18514761

9 

Farré ML, Ferrer I, Ginebreda A, Figueras M, Olivella L, Tirapu L, et al. Determination of drugs in surface water and wastewater samples by liquid chromatography–mass spectrometry: Methods and preliminary results including toxicity studies with Vibrio fischeri. J Chromatogr A. 2001;938(1-2):187–97. https://doi.org/10.1016/S0021-9673(01)01154-2 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/11771838

10 

Gómez MJ, Martínez Bueno MJ, Lacorte S, Fernández-Alba AR, Agüera A. Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. Chemosphere. 2007;66(6):993–1002. https://doi.org/10.1016/j.chemosphere.2006.07.051 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/16962638

11 

Zhang Y, Geißen SU, Gal C. Carbamazepine and diclofenac: Removal in wastewater treatment plants and occurrence in water bodies. Chemosphere. 2008;73(8):1151–61. https://doi.org/10.1016/j.chemosphere.2008.07.086 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/18793791

12 

Heberer T, Reddersen K, Mechlinski A. From municipal sewage to drinking water: Fate and removal of pharmaceutical residues in the aquatic environment in urban areas. Water Sci Technol. 2002;46(3):81–8. https://doi.org/10.2166/wst.2002.0060 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/12227607

13 

Oaks JL, Gilbert M, Virani MZ, Watson RT, Meteyer CU, Rideout BA, et al. Diclofenac residues as the cause of vulture population decline in Pakistan. Nature. 2004;427(6975):630–3. https://doi.org/10.1038/nature02317 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/14745453

14 

Taggart MA, Cuthbert R, Das D, Sashikumar C, Pain DJ, Green RE, et al. Diclofenac disposition in Indian cow and goat with reference to Gyps vulture population declines. Environ Pollut. 2007;147(1):60–5. https://doi.org/10.1016/j.envpol.2006.08.017 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/17069941

15 

Triebskorn R, Casper H, Heyd A, Eikemper R, Köhler HR, Schwaiger J. Toxic effects of the non-steroidal anti-inflammatory drug diclofenac: Part II. Cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquat Toxicol. 2004;68(2):151–66. https://doi.org/10.1016/j.aquatox.2004.03.015 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/15145225

16 

Paje ML, Kuhlicke U, Winkler M, Neu T. Inhibition of lotic biofilms by diclofenac. Appl Microbiol Biotechnol. 2002;59(4-5):488–92. https://doi.org/10.1007/s00253-002-1042-4 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/12172615

17 

Dastidar SG, Ganguly K, Chaudhuri K, Chakrabarty AN. The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis. Int J Antimicrob Agents. 2000;14(3):249–51. https://doi.org/10.1016/S0924-8579(99)00159-4 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/10773497

18 

Kraigher B, Kosjek T, Heath E, Kompare B, Mandic-Mulec I. Influence of pharmaceutical residues on the structure of activated sludge bacterial communities in wastewater treatment bioreactors. Water Res. 2008;42(17):4578–88. https://doi.org/10.1016/j.watres.2008.08.006 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/18786690

19 

Kraigher B, Mandic-Mulec I. Nitrification activity and community structure of nitrite-oxidizing bacteria in the bioreactors operated with addition of pharmaceuticals. J Hazard Mater. 2011;188(1-3):78–84. https://doi.org/10.1016/j.jhazmat.2011.01.072 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/21316843

20 

Heuer H, Smalla K. Application of denaturing gradient gel electrophoresis (DGGE) and temperature gradient gel electrophoresis (TGGE) for studying soil microbial communities. In: Van Elsas JD, Trevors JT, Wellington EMH, editors. Modern soil microbiology. New York, USA: Marcel Dekker; 1997. pp. 353-73.

21 

GeneScan® reference guide. Chemistry reference for the ABI PRISM® 310 genetic analyser. Applied Biosystems, Geel, Belgium; 2000. Available from:https://assets.thermofisher.com/TFS-Assets/LSG/manuals/cms_040961.pdf.

22 

BioNumerics v. 6.6, Applied Maths NV, Sint-Martens-Latem, Belgium; 2011. Available from:https://download.applied-maths.com/sites/default/files/download/bn_quickguide_0.pdf.

23 

Suzuki MT, Giovannoni SJ. Bias caused by template annealing in the amplification of mixtures of 16S rRNA genes by PCR. Appl Environ Microbiol. 1996;62(2):625–30. https://doi.org/10.1128/AEM.62.2.625-630.1996 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/8593063

24 

Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215(3):403–10. https://doi.org/10.1016/S0022-2836(05)80360-2 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/2231712

25 

Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) Software Version 4.0. Mol Biol Evol. 2007;24(8):1596–9. https://doi.org/10.1093/molbev/msm092 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/17488738

26 

Ausec L, Kraigher B, Mandic-Mulec I. Differences in the activity and bacterial community structure of drained grassland and forest peat soils. Soil Biol Biochem. 2009;41(9):1874–81. https://doi.org/10.1016/j.soilbio.2009.06.010

27 

Ausec L, Zakrzewski M, Goesmann A, Schlüter A, Mandic-Mulec I. Bioinformatic analysis reveals high diversity of bacterial genes for laccase-like enzymes. PLoS One. 2011;6(10):e25724. https://doi.org/10.1371/journal.pone.0025724 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/22022440

28 

Chen YL, Wang CH, Yang FC, Ismail W, Wang PH, Shih CJ, et al. Identification of Comamonas testosteroni as an androgen degrader in sewage. Sci Rep. 2016;6:35386. https://doi.org/10.1038/srep35386 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/27734937

29 

Horinouchi M, Hayashi T, Yamamoto T, Kudo T. A new bacterial steroid degradation gene cluster in Comamonas testosteroni TA441 which consists of aromatic-compound degradation genes for seco-steroids and 3-ketosteroid dehydrogenase genes. Appl Environ Microbiol. 2003;69(8):4421–30. https://doi.org/10.1128/AEM.69.8.4421-4430.2003 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/12902225

30 

Boon N, Goris J, De Vos P, Verstraete W, Top EM. Bioaugmentation of activated sludge by an indigenous 3-chloroaniline-degrading Comamonas testosteroni strain, I2gfp. Appl Environ Microbiol. 2000;66(7):2906–13. https://doi.org/10.1128/AEM.66.7.2906-2913.2000 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/10877785

31 

Qiu X, Wu P, Zhang H, Li M, Yan Z. Isolation and characterization of Arthrobacter sp. HY2 capable of degrading a high concentration of p-nitrophenol. Bioresour Technol. 2009;100(21):5243–8. https://doi.org/10.1016/j.biortech.2009.05.056 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/19540107

32 

Suárez-Ojeda ME, Montón H, Roldán M, Martín-Hernández M, Pérez J, Carrera J. Characterization of a p-nitrophenol-degrading mixed culture with an improved methodology of fluorescence in situ hybridization and confocal laser scanning microscopy. J Chem Technol Biotechnol. 2011;86(11):1405–12. https://doi.org/10.1002/jctb.2644

33 

Selvakumaran S, Kapley A, Kashyap SM, Daginawala HF, Kalia VC, Purohit HJ. Diversity of aromatic ring-hydroxylating dioxygenase gene in Citrobacter. Bioresour Technol. 2011;102(7):4600–9. https://doi.org/10.1016/j.biortech.2011.01.011 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/21295975

34 

Patrauchan MA, Oriel PJ. Degradation of benzyldimethylalkylammonium chloride by Aeromonas hydrophila sp. K. J Appl Microbiol. 2003;94(2):266–72. https://doi.org/10.1046/j.1365-2672.2003.01829.x PubMed: http://www.ncbi.nlm.nih.gov/pubmed/12534818

35 

Reardon KF, Mosteller DC, Bull Rogers JD. Biodegradation kinetics of benzene, toluene, and phenol as single and mixed substrates for Pseudomonas putida F1. Biotechnol Bioeng. 2000;69(4):385–400. https://doi.org/10.1002/1097-0290(20000820)69:4<385::AID-BIT5>3.0.CO;2-Q PubMed: http://www.ncbi.nlm.nih.gov/pubmed/10862677

36 

Gröning J, Held C, Garten C, Claußnitzer U, Kaschabek SR, Schlömann M. Transformation of diclofenac by the indigenous microflora of river sediments and identification of a major intermediate. Chemosphere. 2007;69(4):509–16. https://doi.org/10.1016/j.chemosphere.2007.03.037 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/17524452

37 

Pieper DH. Aerobic degradation of polychlorinated biphenyls. Appl Microbiol Biotechnol. 2005;67(2):170–91. https://doi.org/10.1007/s00253-004-1810-4 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/15614564

38 

Rodarte-Morales AI, Feijoo G, Moreira MT, Lema JM. Biotransformation of three pharmaceutical active compounds by the fungus Phanerochaete chrysosporium in a fed batch stirred reactor under air and oxygen supply. Biodegradation. 2012;23(1):145–56. https://doi.org/10.1007/s10532-011-9494-9 PubMed: http://www.ncbi.nlm.nih.gov/pubmed/21695453

39 

Bessa VS, Moreira IS, Tiritan ME, Castro PML. Enrichment of bacterial strains for the biodegradation of diclofenac and carbamazepine from activated sludge. Int Biodeter Biodegr. 2017;120:135–42. https://doi.org/10.1016/j.ibiod.2017.02.008

40 

Aissaoui S, Ouled-Haddar H, Sifour M, Harrouche K, Sghaier H. Metabolic and co-metabolic transformation of diclofenac by Enterobacter hormaechei D15 isolated from activated sludge. Curr Microbiol. 2017;74(3):381–8. https://doi.org/10.1007/s00284-016-1190-x PubMed: http://www.ncbi.nlm.nih.gov/pubmed/28175958


This display is generated from NISO JATS XML with jats-html.xsl. The XSLT engine is libxslt.